Craneware plc AGM Statement and Capital Markets Day (3859G)
06 November 2018 - 6:00PM
UK Regulatory
TIDMCRW
RNS Number : 3859G
Craneware plc
06 November 2018
Craneware plc
("Craneware", "the Group" or the "Company")
AGM Statement and Capital Markets Day
6 November 2018 - Craneware plc (AIM: CRW.L), the leader in
Value Cycle solutions for the US healthcare market, will be holding
its Annual General Meeting today at 1pm. At the meeting, Keith
Neilson, CEO of the Company, will make the following statement:
"We have experienced a positive start to trading in the first
four months of the year, in line with management expectations.
Strong demand has continued across our enlarged product suite, from
both new and existing customers.
"Our recent Financial Performance Summit in the US was the most
well attended in the history of the Company, with representatives
from approximately 600 hospitals. From the workshops and panel
discussions at the event, it is evident that the move to
value-based care is growing in momentum and hospitals are preparing
for this shift. As we launch our new Trisus products over the
coming weeks and continue to invest in future products over the
coming years, we see the opportunity for Craneware to become a
major player in the healthcare market, ensuring hospitals have the
tools to thrive in this near era, improving both margins and
patient outcomes.
"With a continued high level of recurring revenues, a growing
customer base, healthy cash balances and significantly increased
addressable market through our expanding product suite, we look to
the future with confidence."
Capital Markets Day
Craneware is holding a Capital Markets Day for institutional
investors and analysts this morning at 9am in the offices of Peel
Hunt in London. The presentations will discuss the evolution of the
US healthcare market and provide further insight into Craneware's
newly launched Trisus products, including Trisus Healthcare
Intelligence. Keith Neilson, CEO, and Craig Preston, CFO, will be
joined by other members of the Craneware Board and senior
leadership team. No further update on trading will be provided.
Presentation materials will be made available on the Company's
website at www.craneware.com.
For further information, please contact:
Craneware plc +44 (0)131 550 3100
Keith Neilson, CEO / Craig Preston,
CFO
Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900
Dan Webster/ George Sellar
Investec Bank (Joint Broker) +44 (0) 20 7597 5970
Patrick Robb/ Sebastian Lawrence/
Henry Reast
Alma (Financial PR) +44 (0) 7779 664 584
Caroline Forde/ Robyn Fisher/ Josh
Royston
About Craneware
Craneware enables healthcare providers to improve margins and
enhance patient outcomes so they can continue to provide quality
outcomes for all.
Craneware is the leader in automated Value Cycle solutions that
help US Healthcare provider organisations discover, convert and
optimise assets to achieve best clinical outcomes and financial
performance. Founded in 1999, Craneware is headquartered in
Edinburgh, Scotland with offices in Atlanta and Pittsburgh
employing over 320 staff. Craneware's market-driven, SaaS solutions
normalise disparate data sets, bringing in up-to-date regulatory
and financial compliance data to deliver value at the points where
clinical and operational data transform into financial
transactions, creating actionable insights that enable informed
tactical and strategic decisions. To learn more, visit
craneware.com and thevaluecycle.com.
Learn more at www.craneware.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
AGMBABITMBJMBAP
(END) Dow Jones Newswires
November 06, 2018 02:00 ET (07:00 GMT)
Craneware (LSE:CRW)
Historical Stock Chart
From Apr 2024 to May 2024
Craneware (LSE:CRW)
Historical Stock Chart
From May 2023 to May 2024